Europe Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical, Medical Devices, Research and Development, and Others)
Market Introduction
Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.
Get more information on this report :
Market Overview and Dynamics
The Europe biopharmaceutical tubing market is expected to reach US$ 1,474.45 million by 2028 from US$ 827.65 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand for minimally invasive procedures. However, stringent regulatory framework by government for biopharmaceutical applications is expected to restrict the market growth during the forecast period.
Popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing. Also, growing use of platinum-cured silicone as material of choice for biopharmaceutical tubing offers several advantages over traditional peroxide cured tubing. For instance, in January 2020, Watson-Marlow Fluid Technology Group (WMFTG) launched BioPure silicone transfer tubing to confer safe, reliable, and cost-effective solution for a wide range of bioprocess fluid transfer applications. Therefore, the launch and use of platinum-cured silicone tubing as a material of choice is likely to emerge as a significant trend in the biopharmaceuticals market during the forecast period. Thus, there are significant opportunities for the market players to enter the market with superior and cost-effective products.
The COVID-19 pandemic has severely affected the industries in European Union (EU). As the number of COVID-19 patients requiring ventilatory support (high-flow oxygen therapy, non-invasive ventilation, invasive mechanical ventilation, and extracorporeal membrane oxygenation) has increased, the demand for medical tubing has also increased in the last year. In addition, growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes is also influencing the growth of the market, which, in turn propel the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, and spacer devices. Further, the presence of a robust industrial base and several established manufacturers of medical tubing in the country is strengthening the market growth in the country. These factors are expected to fuel the demand for biopharmaceutical tubing in the region during the forecast period.
Key Market Segments
Based on type, the Europe biopharmaceutical tubing market is segmented into plastic, metal, and silicone. The silicone segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the Europe biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe biopharmaceutical tubing market are the European Union (EU), British Heart Foundation (BHF), European Society of Cardiology (ESC) and Italian Institute of Statistics (ISTAT).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe biopharmaceutical tubing market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe biopharmaceutical tubing market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe biopharmaceutical tubing market.
EUROPE BIOPHARMACEUTICAL TUBING MARKET SEGMENTATION
By Type
- Silicone
- Plastic
- Metal
By Application
- Pharmaceutical
- Medical Devices
- Research and Development
- Others
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Biopharmaceutical Tubing Market – By Type
1.3.2 Europe Biopharmaceutical Tubing Market – By Application
1.3.3 Europe Biopharmaceutical Tubing market – By Country
2. Biopharmaceutical Tubing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Biopharmaceutical Tubing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Expert Opinions
5. Biopharmaceutical Tubing Market – Key Market Dynamics
5.1 Drivers
5.1.1 Increasing Elderly Population in World
5.1.2 Rising Demand for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Future Trends
5.3.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing
5.4 Impact Analysis
6. Biopharmaceutical Tubing Market –Europe Analysis
6.1 Europe Biopharmaceutical Tubing Market Revenue Forecast and Analysis
7. Biopharmaceutical Tubing Market Analysis – By Type
7.1 Overview
7.2 Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
7.3 Plastic
7.3.1 Overview
7.3.2 Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metal
7.4.1 Overview
7.4.2 Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Silicone
7.5.1 Overview
7.5.2 Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8. Biopharmaceutical Tubing Market Analysis – By Application
8.1 Overview
8.2 Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
8.3 Pharmaceutical
8.3.1 Overview
8.3.2 Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Medical Devices
8.4.1 Overview
8.4.2 Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Research and Development
8.5.1 Overview
8.5.2 Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
9. Biopharmaceutical Tubing Market – Europe Analysis
9.1 Europe: Biopharmaceutical Tubing Market
9.1.1 Overview
9.1.2 Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028(%)
9.1.2.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 Germany: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.1.3 Germany: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.2 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 France: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.2.3 France: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.3 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 UK: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.3.3 UK: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.4 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 Italy: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.4.3 Italy: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.5 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.1 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.2 Spain: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.5.3 Spain: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.6 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.1 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.2 Rest of Europe: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.6.3 Rest of Europe: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Biopharmaceutical Tubing Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Biopharmaceutical Tubing Market – Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 W. L. Gore and Associates, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Saint-Gobain Sekurit
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Freudenberg Group
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 RAUMEDIC AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 TEKNI-PLEX
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NewAge Industries, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Optinova
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Zeus Industrial Products, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NORDSON CORPORATION
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 DuPont de Nemours, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. France: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. France: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Italy: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Italy: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Spain: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Spain: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of Europe: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Europe: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Biopharmaceutical Tubing Market
LIST OF FIGURES
Figure 1. Biopharmaceutical Tubing Market Segmentation
Figure 2. Biopharmaceutical Tubing Market Segmentation, By Country
Figure 3. Biopharmaceutical Tubing Market Overview
Figure 4. Silicone Segment Held Largest Share of Biopharmaceutical Tubing Market
Figure 5. Europe Biopharmaceutical Tubing Market – Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. Europe Biopharmaceutical Tubing Market – Revenue Forecast and Analysis – 2020- 2028
Figure 8. Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
Figure 9. Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
Figure 13. Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 18. Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 19. Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in European Countries
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe biopharmaceutical tubing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.